Thomas G. DeLoughery, MD, MACP, FAWM | oneAMYLOIDOSISvoice
Healthcare Professionals

Thomas G. DeLoughery, MD, MACP, FAWM

Healthcare Professional
Professor of Medicine, Pathology and Pediatrics
Divisions of Hematology/Oncology and Laboratory Medicine
Oregon Health & Science University (OHSU)
3181 S.W. Sam Jackson Park Road
Portland, Oregon, United States
Tom DeLoughery is a native Hoosier who graduated from Indiana State University in 1981. He received his medical degree from Indiana University School of Medicine, Indianapolis Indiana and did his internship at the University of California, Irvine before traveling to Oregon where he finished his internal medicine residency and hematology/oncology fellowship. Dr. DeLoughery has an expertise in cancer and blood disorders with special focus on amyloidosis, benign blood disorders and blood diseases.

He is currently a professor of medicine, pathology and pediatrics in the Divisions of Hematology/Oncology and Laboratory Medicine at Oregon Health & Science University (OHSU). His clinical interests are in blood diseases, hemostasis, and thrombosis subjects on which he has written extensively. He has won numerous teaching awards and has given education sessions to national meetings of many professional societies. He is the course director for the medical school Blood Course and was a co-developer of the Blood and Host Defense course for the New Curriculum. He also has an interest in the hematologic aspects of sport and travel medicine and has served six years on the board of directors of the Wilderness Medicine Society and has chaired their research committee.

Tom DeLoughery is a master at the American College of Physicians and Fellows of the Academy of Wilderness Medicine. The 3rd edition of his popular handbook Hemostasis and Thrombosis was published this year.

Representative Publications:


The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.